Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging

Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma

(2012) Paolo P. Provenzano et al.   CANCER CELL

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer

(2012) J. A. O'Shaughnessy et al.   ONCOLOGIST

Peptides for cell-selective drug delivery

(2012) Nina Svensen et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery

(2011) Ruei-Min Lu et al.   BIOMATERIALS

Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin

(2011) Hyun-Jong Cho et al.   BIOMATERIALS

Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors

(2011) S. I. Rudnick et al.   CANCER RESEARCH

Liposomal drug formulations in cancer therapy: 15 years along the road

(2011) Marije Slingerland et al.   DRUG DISCOVERY TODAY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers

(2011) Carlee E. Ashley et al.   NATURE MATERIALS

Other Options in the Treatment of Advanced Breast Cancer

(2011) Melody A. Cobleigh   SEMINARS IN ONCOLOGY

The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment

(2010) WW Cheng et al.   Expert Opinion on Drug Delivery

Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications

(2010) Jinjun Shi et al.   NANO LETTERS

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein

(2010) Tao Wang et al.   Nanomedicine

Impact of Nanotechnology on Drug Delivery

(2009) Omid C. Farokhzad et al.   ACS Nano

Is Anticancer Drug Development Heading in the Right Direction?

(2009) Trevor W. Hambley   CANCER RESEARCH

Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors

(2009) De-Kuan Chang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer

(2009) De-Kuan Chang et al.   PLoS One

Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting

(2009) Ji-Ho Park et al.   Small

Drug delivery in acute myeloid leukemia

(2008) Johannes Kohlschütter et al.   Expert Opinion on Drug Delivery

Antibody-modified liposomes for cancer chemotherapy

(2008) Vladimir Torchilin   Expert Opinion on Drug Delivery

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

(2008) Felix Kratz   JOURNAL OF CONTROLLED RELEASE

Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery

(2008) A. Lo et al.   MOLECULAR CANCER THERAPEUTICS

Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging

(2008) Weibo Cai et al.   Nature Protocols

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY

Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification

(2005) David F. Nellis et al.   BIOTECHNOLOGY PROGRESS